The data of MARCH ( Metformin and AcaRbose in Chinese as the initial Hypoglycaemic treatment ) trial demonstrated that acarbose and metformin have similar efficacy as initial therapy for hemoglobin A@c ( HbA@c ) reduction in Chinese patients with newly diagnosed type @ diabetes .